Good to hear about the new focus on other types of

Good to hear about the new focus on other types of breast cancers besides mTNBC. When Kelly was asked if the original mTNBC patients status have been followed up on, he said yes, but basically because of the small trial size the data was not useful. Better answer would have been we are encouraged by what we have seen in extending the lives of some of the women. Too Nadarlike I guess. Seems they were bending over backwards to not say anything directly positive about LL. But at least we have plan.